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Clinical Infectious Diseases
MAJOR ARTICLE
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Background. Enteropathogen infections have been associated with enteric dysfunction and impaired growth in children in lowresource settings. In a multisite birth cohort study (MAL-ED), we describe the epidemiology and impact of Campylobacter infection
in the ﬁrst 2 years of life.
Methods. Children were actively followed up until 24 months of age. Diarrheal and nondiarrheal stool samples were collected
and tested by enzyme immunoassay for Campylobacter. Stool and blood samples were assayed for markers of intestinal permeability
and inﬂammation.
Results. A total of 1892 children had 7601 diarrheal and 26 267 nondiarrheal stool samples tested for Campylobacter. We describe a high prevalence of infection, with most children (n = 1606; 84.9%) having a Campylobacter-positive stool sample by 1 year of
age. Factors associated with a reduced risk of Campylobacter detection included exclusive breastfeeding (risk ratio, 0.57; 95% conﬁdence interval, .47–.67), treatment of drinking water (0.76; 0.70–0.83), access to an improved latrine (0.89; 0.82–0.97), and recent
macrolide antibiotic use (0.68; 0.63–0.74). A high Campylobacter burden was associated with a lower length-for-age Z score at 24
months (−1.82; 95% conﬁdence interval, −1.94 to −1.70) compared with a low burden (−1.49; −1.60 to −1.38). This association was
robust to confounders and consistent across sites. Campylobacter infection was also associated with increased intestinal permeability
and intestinal and systemic inﬂammation.
Conclusions. Campylobacter was prevalent across diverse settings and associated with growth shortfalls. Promotion of exclusive
breastfeeding, drinking water treatment, improved latrines, and targeted antibiotic treatment may reduce the burden of Campylobacter infection and improve growth in children in these settings.
Keywords. Campylobacter; children; risk factors; growth; inﬂammation.

Enteropathogen infection has been associated with impaired
growth in young children in low-resource settings [1–4],
which in turn has been associated with long-term sequelae,
with signiﬁcant implications for health and human capital [5–
7]. Recent work has implicated Campylobacter [2, 3], with the
putative mechanism being environmental enteric dysfunction,
a condition characterized by altered intestinal function and
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inﬂammation [8–10]. In high-resource settings, Campylobacter
infection is sporadic and associated with exposure to undercooked chicken [11, 12], or less frequently common-source outbreaks, often due to contaminated dairy products [13]. In
contrast, in low-resource settings, Campylobacter infection is
frequently endemic [2, 14]. Although exposure to poultry may
be important, identiﬁed determinants are varied [11, 15–17].
The Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health
and Development Project (MAL-ED) is a birth cohort study
performed at 8 sites in South America, sub-Saharan Africa,
and Asia [18]. Notably, MAL-ED used an enzyme immunoassay (EIA) to detect Campylobacter in stool samples, which is
substantially more sensitive than stool culture [19]. Previous
work found Campylobacter to have the highest attributable burden of diarrhea in this study [20]. Finally, asymptomatic
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Epidemiology and Impact of Campylobacter Infection in
Children in 8 Low-Resource Settings: Results From the
MAL-ED Study

infection with enteropathogens was strongly associated with linear growth shortfalls, with a uniquely strong association between Campylobacter and growth (MAL-ED investigators,
manuscript in preparation). In the present work, we aimed to
describe the burden and impact of Campylobacter and identify
potential interventions to reduce infection with this pathogen.

Study Design and Procedures

The MAL-ED study design and methodology have been described elsewhere [18]. The study was conducted at 8 sites:
Dhaka, Bangladesh; Vellore, India; Bhaktapur, Nepal; Naushero
Feroze, Pakistan; Venda, South Africa; Haydom, Tanzania; Fortaleza, Brazil; and Loreto, Peru. Children were enrolled from
November, 2009 to February, 2012 and followed up through
24 months of age. Monthly anthropometry was performed
[21]. Stool samples were collected in the absence of diarrhea
at 1–12, 15, 18, 21, and 24 months of age as well as from
each diarrhea episode, deﬁned as maternal report of ≥3 loose
stools in 24 hours or visible blood in stool and identiﬁed
through twice-weekly home visits.
Caregivers were surveyed biannually from 6 months of age,
including questions about maternal income and education,
the home environment, drinking water source and treatment,
and the presence of animals. Crowding was deﬁned as >2 persons per room living in the home. An improved latrine and
water source were deﬁned following World Health Organization
guidelines [22]. Treatment of drinking water was deﬁned as
boiling, ﬁltering, or adding bleach. Poor access to water was deﬁned as having a primary drinking water source more than a
10-minute walk from the home. Twice-weekly home surveillance assessed breastfeeding in the prior day as exclusive (no
consumption of other food or liquid), partial, or none, identiﬁed the introduction of speciﬁc foods, and recorded antibiotic
use. All sites received ethical approval from their respective governmental, local institutional, and collaborating institutional review boards. Written informed consent was obtained from the
parent or guardian of each child.
Laboratory Testing

The laboratory methods used in the MAL-ED study have been
described elsewhere [10, 23]. Pertinently, EIA was performed for
Campylobacter (ProSpecT) as well as Giardia and Cryptosporidium (TechLab). Monthly surveillance stool samples were also
tested for myeloperoxidase (MPO; measured in nanograms
per milliliter), a marker of neutrophil activity in the intestinal
mucosa (Alpco); neopterin (NEO; measured in nanomoles
per liter), a marker of T-helper cell 1 activity (GenWay Biotech);
and α-1-antitrypsin (AAT; measured in milligrams per gram), a
marker of intestinal permeability (Biovendor). Blood samples
collected at 7, 15 and 24 months were tested for α-1-acid
1172
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Data Analysis

To identify factors associated with Campylobacter detection in
surveillance stool samples, we used generalized estimating equations to ﬁt a generalized linear model with a ﬁrst-order autoregressive working correlation matrix and robust variance to
account for nonindependence of stool testing within each
child. To estimate risk ratios for Campylobacter detection, we
used Poisson regression as an approximation of log-binomial
regression since the log-binomial models did not converge
[24]. First, we estimated the association for each factor of interest with Campylobacter detection, adjusting for age (using a natural spline with knots at 6, 12, and 18 months), sex, site, and
season via the terms sin(2mp=12Þ þ cos(2mp=12Þ, where m
is the month of the year as well as—given possible variation
in seasonality between sites—an interaction between these
terms and site [25]. Then, based on statistical signiﬁcance,
model ﬁt based on the quasi-likelihood information criterion
and an assessment of covariance between individual factors,
we ﬁt a multivariable model. We also ﬁt site-speciﬁc models, excluding those variables from the multivariable model that did
not vary within speciﬁc sites. Finally, to further describe any
association with recent antibiotic use, we ﬁt 2 multivariable
models, adjusted as described above, which included (1) classspeciﬁc antibiotic use in the prior month and (2) class-speciﬁc
use in 15-day windows over the prior 60 days.
For the analysis of linear growth, included individuals were
required to have a length-for-age Z (LAZ) score at 24 months
of age. We excluded children from the Pakistan site, owing to
bias noted in a subset of length measurements at this site. To
estimate the association between the burden of detection of
an individual pathogen and 24-month LAZ score, we calculated
the enteropathogen burden for each subject using the surveillance stool samples (namely, samples positive/samples tested).
Similar burden indices were calculated for the 0–6, 7–12, and
13–24 month intervals. Persistent infection was deﬁned as detection of Campylobacter from all surveillance stool samples
tested during a 3-month period. We then ﬁt a multiple linear
regression, including enrollment LAZ score, sex, site, and Campylobacter burden and further adjusted for possible confounders, including factors associated with Campylobacter infection
in the multivariable model as well as highly-correlated pathogens. To calculate model-predicted 24-month LAZ scores, we
calculated predicted population marginal effects using leastsquares means [26]. Overall and site-speciﬁc high and low
burdens of Campylobacter were deﬁned as the 90th and 10th
percentile of Campylobacter burden, respectively.
To estimate the association between Campylobacter detection
and fecal markers of intestinal permeability and inﬂammation
collected in surveillance stool samples (MPO, NEO, and AAT),
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glycoprotein (AGP; measured in milligrams per deciliter), a
marker of systemic inﬂammation.

RESULTS

A total of 2145 children were enrolled, of whom 2087 had ≥1
surveillance stool sample tested for Campylobacter, and 1892
additionally had ≥1 biannual survey performed. These 1892
children had 7601 diarrheal and 26267 surveillance stool samples tested by Campylobacter EIA (Supplementary Table 1).
Campylobacter prevalence in diarrheal and surveillance stool
samples varied substantially by site (Figure 1). Generally, Campylobacter was frequently detected in surveillance stool samples,
with an increasing prevalence over the ﬁrst year of life and with
peak prevalence varying by site, ranging from approximately

10% of surveillance stool samples in Brazil and South Africa
to more than half in Bangladesh, Pakistan, and Tanzania. Approximately half of the children had a Campylobacter-positive
stool sample by 6 months of age, and most (n = 1606; 84.9%)
had a Campylobacter-positive stool sample by 1 year of age
(Supplementary Figure 1). For some sites, exposure was much
earlier (eg, in Pakistan, the majority of children had a Campylobacter-positive stool sample by 3 months of age). The median
proportion of surveillance stool samples positive for Campylobacter from 0–24 months was 0.20 (interquartile range, 0.11–
0.38).
Possible sociodemographic, environmental, and behavioral
determinants of Campylobacter infection varied substantially
between sites, including crowding in the home (4.7%–83.2%),
routine treatment of drinking water (0%–56.5%), and access
to an improved latrine (15.1%–100%) (Supplementary Table 1).
Overall, the duration of exclusive breastfeeding was short (median, 3.2 months; interquartile range, 2.0–5.3 months) (Supplementary Table 1), and fewer than half of children were
exclusively breastfed to 6 months [27]. Nonexclusive breastfeeding generally continued beyond 12 months, with variable cessation in the second year. We identiﬁed factors associated with
Campylobacter detection in surveillance stool samples across
all sites (Table 1) and for individual sites (Figure 2). Despite
substantial heterogeneity between sites, exclusive breastfeeding

Figure 1. Campylobacter prevalence in diarrheal and nondiarrheal surveillance stool samples. Histogram shows proportions of diarrheal (black) and surveillance (gray) stool
samples positive for Campylobacter by enzyme immunoassay by age at each site.
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we used generalized estimating equations to ﬁt a generalized linear model, as described previously but using a gaussian distribution. These models adjusted for age, sex and site, as
previously described, and we also ﬁt site-speciﬁc models. Finally, to describe the association between Campylobacter burden
and systemic inﬂammation, we ﬁt multiple linear regression
models and calculated predicted population marginal effects
using least-squares means, both for the entire cohort and for
each site, as described for the analysis of linear growth, but
with the mean AGP value for each individual as the response
variable instead of 24-month LAZ score. All statistical analysis
was performed using R software, version 3.2.2 (Foundation for
Statistical Computing).

Table 1. Risk Factors for Campylobacter Detection in Surveillance Stool
Samples
Risk Ratio (95% CI)
Univariable
Analysisa

Risk Factors by Category

Multivariable
Analysisb

Sociodemographic/maternal
1.06 (1.01–1.12)

1.05 (1.00–1.11)

0.95 (.89–1.03)

0.93 (.87–1.00)

Crowding in the home

1.19 (1.11–1.27)

1.13 (1.05–1.21)

Maternal educational level <6 y

1.16 (1.09–1.24)

1.08 (1.01–1.15)

Monthly income <$150

1.14 (1.07–1.22)

1.04 (.97–1.11)

Breastfeeding/diet
Proportion of breastfeeding in
prior mo
Exclusive

0.54 (.46–.62)

0.56 (.47–.67)

Nonexclusive

1.22 (1.14–1.30)

1.02 (.95–1.10)
1.06 (.96–1.17)

Consumption in prior mo
Water

1.24 (1.13–1.36)

Animal milk

1.06 (1.01–1.12)

. . .

Solid food

1.21 (1.09–1.34)

. . .

1.08 (1.01–1.16)

. . .

Child observed to eat nonfood
items
Antibiotics in prior mo

0.86 (.83–.89)

0.86 (.83–.90)

Routine treatment of drinking
water

0.72 (.66–.78)

0.75 (.69–.82)

Improved source of drinking
water

0.93 (.82–1.04)

0.96 (.85–1.07)

Poor access to water

1.22 (1.10–1.34)

1.16 (1.06–1.28)

0.85 (.78–.92)

0.89 (.81–.97)

Water

Sanitation: access to an improved
latrine
Environment
Dirt floor in home

1.16 (1.07–1.25)

1.04 (.96–1.13)

Chickens kept at home

1.07 (.99–1.15)

1.06 (.99–1.13)

Cattle kept at home

1.04 (.96–1.12)

. . .

Agricultural land ownership

0.99 (.92–1.07)

. . .

Abbreviations: CI, confidence interval; WAZ score, weight-for-age Z score.
a

Adjusted for age, sex, site, and season.

b

Adjusted for age, site, season, and all variables included in multivariable model.

in the prior month, routine treatment of drinking water, and access to an improved latrine were most consistently associated
with a reduced risk of Campylobacter detection. Keeping chickens was marginally associated with increased Campylobacter detection, and consumption of chicken was not common in these
children (data not shown).
Antibiotic use varied between sites from on average <1 to almost 10 courses of antibiotics per child-year (Supplementary
Table 1). Antibiotic use in the prior month was consistently associated with a reduced risk of Campylobacter detection
(Table 1, Figure 2). Among all classes, macrolide, cephalosporin, penicillin, and ﬂuoroquinolone use were associated with a
reduced risk of detection (Table 2), and macrolide use was associated with the most prolonged clearance of Campylobacter
from stool, with a signiﬁcant association for macrolide use in
the previous 45 days (Figure 3).
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Female sex
Low birth weight (WAZ score
<2)

To examine whether Campylobacter detection served as a
marker of infection with other enteropathogens, we examined
the correlation between the total Campylobacter burden from
both surveillance and diarrheal stool samples for each individual with that of non-Campylobacter bacterial, viral, and parasitic enteropathogens (Supplementary Figure 2). At all sites,
Campylobacter burden was more strongly correlated with the
burden of parasitic enteropathogens (Pearson correlation coefﬁcient, 0.35; P < .001) than with non-Campylobacter bacterial
(0.01; P = .55) or viral enteropathogens (0.25; P < .001). Protozoal parasites were more strongly associated than helminths
(0.35 vs 0.09; both P < .001). The majority of protozoal enteropathogen detections were either Giardia or Cryptosporidium,
and Giardia correlated most strongly with Campylobacter
(0.32 vs 0.21; both P < .001).
For the 7 sites included in the growth analysis, 1426 of 1892
children had anthropometry performed at enrollment and 24
months. The predicted 24-month LAZ score, adjusted for
LAZ score at enrollment and site, was −1.90 (95% conﬁdence
interval [CI], −1.99 to −1.80) for children with high Campylobacter burden and −1.49 (−1.56 to −1.42) for those with low
Campylobacter burden. The association persisted after adjustment for potential confounders, speciﬁcally sex, crowding in
the home, maternal education, monthly income, duration of exclusive breastfeeding, antibiotic use, routine treatment of drinking water, poor access to drinking water, access to an improved
latrine, and keeping chickens (high burden, −1.82 [95% CI,
−1.94 to −1.70]; low burden, −1.49 [−1.60 to −1.38]).
In site-speciﬁc analyses, despite substantial variation in both
Campylobacter prevalence and associated determinants, the effect was consistent (Figure 4A). Additionally adjusting for parasite burden did not substantially change the effect size (0.29
difference in 24-month LAZ score between high and low Campylobacter burden after adjustment vs 0.33), and parasite burden was not signiﬁcantly associated with 24-month LAZ
score. We also assessed whether the timing of the Campylobacter infection modiﬁed the association between Campylobacter
burden and length attainment, and although the association
was seen across all age ranges, it was most notable in children
aged 7–12 months (Figure 4B). A total of 412 children (28.9%)
had ≥1 persistent Campylobacter infection during the ﬁrst year
of life. After adjustment for overall burden, having a persistent
infection was not associated with 24-month LAZ score (change
in 24-month LAZ score, 0.01; 95% CI, −.13 to .15).
We then estimated the association between Campylobacter
infection and fecal markers of intestinal permeability and inﬂammation as well as systemic inﬂammation. Campylobacter
was detected in ≥1 surveillance stool sample in 1680 of 1892
children (88.8%). With adjustment for age, sex, and site, Campylobacter-positive stool samples were associated with higher
MPO (difference in log concentration, 0.18 ng/mL; 95% CI,
.13–.22 ng/mL) and AAT (0.05 mg/g; 0.02–0.09 mg/g) and

lower NEO (−0.12 nmol/L; −0.16 to −0.08 nmol/L) concentrations (Figure 5A). The concentration of MPO was higher at the
time of the ﬁrst Campylobacter detection (mean [standard deviation], 8.94 [1.24]) than in the month prior (8.86 [1.27];
paired t test P < .001) or in the month after (8.84 [1.25];
P < .001). No such differences were observed for AAT and
NEO. Of the 1426 children included in the growth analysis,
1383 had ≥1 blood sample tested for AGP. A high Campylobacter burden was associated with a higher mean AGP concentration (difference between high and median burden, 7.1 mg/dL

Table 2. Association Between Antibiotic Class Administration in the
Prior Month and Campylobacter Detection in Surveillance Stool Samples
Antibiotic Class

Antibiotic Courses, No.

Risk Ratio (95% CI)

Macrolide

2820

0.68 (.63–.74)

Cephalosporin

3534

0.80 (.76–.85)

Fluoroquinolone
Penicillin

692

0.89 (.78–1.02)

6577

0.92 (.88–.96)

Metronidazole

2289

0.95 (.87–1.02)

Other/unknown

2761

0.95 (.89–1.02)

Sulfonamide

1560

1.02 (.94–1.10)

Tetracycline

42

1.03 (.58–1.83)

Abbreviation: CI, confidence interval.

[95% CI, 2.7–11.4]; difference between low and median burden
−2.8 [95% CI, −6.6–.9)] (Figure 5B). This association was consistent across sites.
DISCUSSION

As a prospective, multisite birth cohort study, MAL-ED is the
ﬁrst to use a culture-independent diagnostic for Campylobacter,
which affords a substantial increase in sensitivity over selective
culture [19]. We describe an astonishingly high prevalence of
Campylobacter infection beginning early in life and a negative
association between Campylobacter burden and linear growth
that is consistent across sites and persists after adjusting for potential confounders. The second half of the ﬁrst year of life
seems the most critical period for Campylobacter-associated
growth shortfalls, with a large increase in Campylobacter prevalence during that time period. These ﬁndings build on evidence from the MAL-ED study that subclinical infections
with enteropathogens were more strongly linked to linear
growth shortfalls than overt diarrhea (MAL-ED investigators,
manuscript in preparation).
Campylobacter was associated with increased intestinal permeability and local and systemic inﬂammation, suggesting a
mechanism for the association with reduced linear growth
[8]. This is consistent with ample evidence that Campylobacter
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Figure 2. Site-level sensitivity analysis of risk factors for Campylobacter detection in surveillance stool samples. Risk ratios with 95% confidence intervals (CIs) are shown
for risk factors of interest as identified in the overall model (Table 1). All estimates are adjusted for age, sex, season, and the factors shown in the figure. Factors that did not
vary at each site were excluded. Abbreviation: WAZ score, weight-for-age Z score.

can drive intestinal inﬂammation, in part by altering the composition of the intestinal microbiota, impairing the intestinal
barrier, and priming the intestine for chronic inﬂammatory responses [9, 28–32]. Fecal NEO concentrations were lower in the
setting of Campylobacter infection, which may support that
Campylobacter drives inﬂammation primarily via the innate immune system. A preliminary analysis of a subset of infants aged
0–9 months showed an association between fecal NEO and
growth [33], but this association was not seen in the ﬁnal analysis of the complete cohort.
Despite heterogeneity between sites, factors associated with
reduced Campylobacter detection included exclusive breastfeeding, treatment of drinking water, access to an improved latrine,
and recent use of antibiotics, particularly macrolides. These
ﬁndings are consistent with other studies which have shown exclusive breastfeeding, water quality, and sanitation to be
1176
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Figure 3. Timing and class of antibiotic use and Campylobacter detection in surveillance stool samples. Risk ratios and 95% confidence intervals (CIs) are derived
from a single model adjusted for age, sex, site, season, and all shown windows for
antibiotic use.

important determinants of Campylobacter infection [34, 35].
These observations, along with the correlation between infection with Campylobacter and intestinal parasites, are suggestive
of diffuse environmental exposure to Campylobacter.
Breastfeeding is thought to reduce the risk of Campylobacter
infection in infants via passive immunity [36] as well as reducing exposure to the environment, although it has not been
shown to improve growth [37]. In the present study, protection
was associated with exclusive breastfeeding but not with nonexclusive breastfeeding. However, the observed burden and impact of Campylobacter infection extends well beyond the
commonly recommended duration of exclusive breastfeeding.
The impact of water and sanitation interventions on Campylobacter infection has not been evaluated. Clinical trials of water
treatment [38] and latrine promotion and construction [39] in
India failed to reduce all-cause diarrheal incidence but did not
interrogate for speciﬁc enteropathogens. A trial of a community-led sanitation program in Mali showed a signiﬁcant improvement in linear growth [40], an effect that was largest for children
<2 years of age, despite no decrease in diarrhea. Intriguingly, the
prevalence of bloody diarrhea was reduced, and Campylobacter
was the primary etiology of bloody diarrhea in infants in the
MAL-ED cohorts [20]. Further studies are needed to assess
the impact of these interventions on enteropathogen infection
and child growth [41].
The observed association between antibiotic use, in particular
of the macrolide class, and clearance of Campylobacter from
surveillance stool samples suggests that antibiotic use could reduce Campylobacter burden and possibly improve growth outcomes in these settings. There is evidence from mass treatment
trials for trachoma that macrolide administration reduced allcause mortality, although it is unclear whether undernutrition
mediated this effect [42]. Estimates from similar trials that compared the frequency of azithromycin administration for trachoma control have suggested some effect of more frequent
azithromycin administration on linear growth [43]. Any observed beneﬁt would have to be weighed against the potential
harms of early antibiotic use, in particular selection for drug resistance and collateral effects on the gut microbiota [44–46].
Our work has several limitations. First, Platts-Mills et al [19]
have shown that the Campylobacter EIA detects a broad range
of Campylobacter species, including species of nonavian origin
and unclear pathogenicity. This may have reduced the association between some risk factors (eg, keeping chickens) and Campylobacter infection as well as the association between
pathogenic Campylobacter species and inﬂammation and
growth. Nucleic acid–based detection may provide a more granular understanding of speciﬁc Campylobacter species [47]. In
the absence of culture isolates and molecular typing, our ability
to distinguish persistent infection from reinfection was limited.
However, the high prevalence and relatively transient clearance
after antibiotic use suggest that reinfection is common. Third,
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Figure 4. Association between Campylobacter burden and length attainment at 24 months. A, Left, Difference in model-predicted 24-month length-for-age Z (LAZ) score
between 10th and 90th percentiles of Campylobacter burden and median Campylobacter burden, overall and at each site. Right, Campylobacter burden expressed as proportion
of surveillance stool samples tested that were positive for Campylobacter. B, Same estimates for overall 10th and 90th percentiles of Campylobacter burden by age interval.
Abbreviation: CI, confidence interval.

Campylobacter Infection in Children

•

CID 2016:63 (1 November)

•

1177

measurement of environmental exposures is difﬁcult, which
may preclude the identiﬁcation of risk factors for Campylobacter infection. Finally, it is possible that Campylobacter infection
is a marker or sequela rather than a cause of reduced linear
growth. An assessment of pathogen carriage and growth in a
study designed to reduce exposure to Campylobacter may better
distinguish these 2 possibilities.
In sum, this work provides strong evidence to suggest that
Campylobacter infection is an important contributor to linear
growth shortfalls in children in low-resource settings, given
the strength, consistency across diverse settings, and persistence
of the observed association with adjustment for potential confounders, the high burden of infection, and the presence of a
plausible mechanism. Promotion of exclusive breastfeeding,
routine treatment of drinking water, access to improved latrines,
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and judicious antibiotic administration may reduce Campylobacter infection and improve linear growth in children in
these settings. We recommend that, in addition to vaccine development, clinical trials be undertaken to reduce Campylobacter infections via such interventions, with both subclinical
pathogen infection and linear growth as outcomes of interest.
Supplementary Data
Supplementary materials are available at http://cid.oxfordjournals.org.
Consisting of data provided by the author to beneﬁt the reader, the posted
materials are not copyedited and are the sole responsibility of the author, so
questions or comments should be addressed to the author.
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Figure 5. Association between Campylobacter detection and fecal markers of intestinal permeability and inflammation (A) and systemic inflammation (B). A, Difference in
the log concentrations of neopterin, α-1-antitrypsin, and myeloperoxidase from surveillance stool samples associated with Campylobacter detection. B, Difference in modelpredicted mean α-1-acid glycoprotein (AGP) concentrations between 10th and 90th percentiles of Campylobacter burden and median Campylobacter burden, both overall and at
each site; blood samples were obtained at 7, 15, and 24 months of age. Abbreviation: CI, confidence interval.
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